Form 4: Assembly Biosciences Director Michael Houghton Acquires Shares

Director Michael Houghton of Assembly Biosciences acquired 3,202 shares of common stock through an IRA at a weighted average price of $15.6145 per share.

Summary

• Michael Houghton, a director at Assembly Biosciences, purchased 3,202 shares of the company's common stock.
• The shares were acquired on December 30, 2024, through an Individual Retirement Account (IRA).
• The purchase was executed at a weighted average price of $15.6145 per share, with individual transaction prices ranging from $15.54 to $15.70.
• The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 6

Explanation: The document reflects a routine insider transaction, which is neither significantly positive nor negative. The director's purchase could be seen as a slightly positive signal, but it's not a major event.

Positives

• A director's purchase of shares can be seen as a positive signal of confidence in the company's future prospects.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the biotechnology industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider trading activity.
• The purchase of shares by a director is a common occurrence and does not indicate any unusual activity compared to other companies.

Stakeholder Impact

• The purchase of shares by a director may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Assembly Biosciences, insider trading, Form 4, share purchase, Michael Houghton, director, IRA, ASMB